体重损失药物正在减少杂货消费,促进服装和健康旅行,改变美国消费者的习惯。 Weight loss drugs are reducing grocery spending, boosting apparel and wellness travel, reshaping U.S. consumer habits.

Wegovy和Zepbound等重量损失药物正在改变美国消费支出, PwC对超过11 000户家庭的分析显示,第一年杂货消费下降6%至8%,同时转向更健康的食品。 Weight loss drugs like Wegovy and Zepbound are changing U.S. consumer spending, with a PwC analysis of over 11,000 households showing a 6% to 8% drop in grocery spending in the first year, along with a shift to healthier foods. 快速食品支出下降,而全套服务餐饮参观增加。 Fast food spending declined, while full-service restaurant visits increased. 在开始治疗后6个月左右,服装支出上升了4%至5%,这可能是由于服装不再合适和信心增强所致。 Apparel spending rose 4% to 5% around six months after starting treatment, likely due to clothing no longer fitting and improved confidence. 以健康为重心的假期也呈增长趋势, 这表明与这些药物有关的更广泛的生活方式和经济转变。 There's also a growing trend toward wellness-focused vacations, indicating broader lifestyle and economic shifts tied to these medications.